WE ARE PHARMATHEN
Our leaders
John Nason
Group CEO
- 30 years of global biopharmaceutical leadership in operational roles at Teva, Bristol Myers Squibb, Novartis, and Sandoz.
- Strong track record ensuring the manufacturing and supply of critical medicines to patients while delivering large capital investments and supporting the people developments needed to secure future growth.
- MBA, B.Sc. in Chemistry and Microbiology.
- Currently holds the position of Group CEO.
Noa Anker
Chief Operating Officer
- MBA and B.Sc. in Chemistry.
- Joined Pharmathen in April 2026 as Chief Operating Officer.
- Strategic results-oriented leader with more than 23 years of progressive experience in the global pharmaceutical industry.
- Extensive experience in leading large and complex operations through transformation of quality, EHS, service and operational excellence culture.
Ernesto Alegria
Group CFO
- Graduate degree in International Relations from Sciences-Po, Paris, France. B.A. in Economics and in Political Sciences from the University of California- Los Angeles (UCLA).
- 2024, joined Pharmathen as Group CFO and is based in the company’s offices in Switzerland.
- Has an extensive career in finance within the Pharmaceutical Industry in both publicly listed and private equity owned companies: Primex Pharmaceuticals, Acino, Takeda, Nycomed.
- Broad international background from Europe, the US, Latin America and other emerging markets.
Efthymios Koutris
Chief Development Officer
- Diploma in Chemical Engineering (M.Sc.Eng.) from Aristotle University of Thessaloniki.
- 2000, started working at Pharmathen holding several roles in Research & Development.
- Scientific achievements: 56 patent certificates & applications and development of more than 90 pharmaceutical products
- Project leader of the design and the investment plan of the 17000m2 production site at Sapes, Komotini.
- Developed innovative drug delivery technologies/products with several applications (PF ophthalmics, sustained release, LAIs etc.).
Mohit Singh
Chief Commercial Officer
- Engineer and MBA from the Indian Institute of Foreign Trade, New Delhi.
- 2013, started working at Pharmathen in Business Development & Portfolio Management roles.
- 16 years of experience, both in Developed and Emerging Markets, in Global Business Development, Strategy and Portfolio Management roles.
- In the past, held leadership positions in various pharmaceutical companies such as Portfolio Lead for Branded Generics and Group Director of Business Development.
Dr. Charalambos Constantinou
Chief of Staff
- PhD in Finance from the University of Cambridge.
- M.Sc. in Finance and Economics from the University of Warwick.
- 2022, started working at Pharmathen as Leader of the Project Management office.
- Has significant experience in large transformation and reorganization programs.
- Held several senior positions in large multinational organizations, including EY and Standard & Poor’s.
Eva Mardomingo Santas
Senior Vice President Quality
- PhD and MBA, Chemical & Industrial Engineer, with a Master’s in Digital Marketing and Lean Six Sigma Black Belt certification.
- Joined Pharmathen in July 2026 as Senior Vice President Quality.
- 22 years of global biopharmaceutical leadership across Quality, Compliance, and Regulatory functions at Genentech, Lonza, Roche, and Chugai, across three continents.
- Proven track record in leading global product launches, complex multi-product integrations, and operational excellence initiatives, ensuring compliance and reliable patient supply.
Maria Provelengiou
Senior Vice President People Officer
- MSc in Chemical Engineering from the National Technical University of Athens and Master's in Strategic HR Management from ALBA Graduate Business School.
- Joined Pharmathen in April 2026 as Senior Vice President People Officer.
- More than 30 years of professional experience across the FMCG, oil and pharmaceutical industries.
- Led regional and global organizational transformation programs.
- Passionate for Digital and Future Fit Skills and for nurturing transformational leaders.
Dr. Sotiria Chaitidou
Vice President R&D Long-Acting Technologies
- PhD in Polymer Science and Technology (development of advanced polymeric materials for bio-separation and drug delivery applications).
- Diploma with distinction in Chemical Engineering (M.Sc.Eng.) from Aristotle University of Thessaloniki & Interdisciplinary Master (M.Sc.) in Nanosciences & Nanotechnologies.
- Started working at Pharmathen in 2009, holding several roles in Research & Development.
- Lead the development of Long-Acting Injectable products-LAIs (polymeric micro and nano particles, micro and nano suspensions, hydrogels).
- Contributed to the technology transfer of LAIs from small to industrial scale.
Arnaud Cosnefroy
Vice President Procurement
- 20+ years of global procurement leadership across Animal Health (Private Equity backed), Industrial and Automotive sectors, managing up to €1bn spend and multinational teams across Europe, the Americas and Asia.
- Strong track record transforming procurement into a centralized & strategic global function in mid-size or large companies.
- Proven ability to secure complex supply chains including in crisis periods and inflation shocks.
George Drossos
Vice President People & Culture
- MBA from University of Hull & B.Sc. in Marketing Management from American College of Greece.
- 2012, joined Pharmathen as Group HR Director.
- With more than twenty years of leadership experience in driving multicultural organizations to high performance culture and achievements through centralization /digitalization of procedures and employer branding actions.
- Developed and implemented a wide range of initiatives focused on the company’s global talent strategy, including staffing, career development and reward systems.
- Improved leadership HR engagement, staff effectiveness and retention as well as developed and implemented HR processes infrastructure globally.
- Under his leadership, the company was awarded as “Best Place to Work” for four consecutive years (2012-2016).
Efstathios Georgiou
Vice President Finance
Yash Khosla
Vice President Commercial - Business Development
- MBA in International Marketing with over 20 years of experience across developed and emerging markets in business development, strategy, commercial operations, and market expansion.
- Joined Pharmathen in 2023 as Head of Business Development for Europe and currently leads the company’s global business development, licensing, and strategic partnerships activities.
- Proven track record in licensing, co-development, and commercialization partnerships across specialty generics, biosimilars, complex injectables, long-acting technologies, and 505(b)(2) programs.
- Focused on driving sustainable growth through strategic collaborations that create long-term value for patients, customers, and stakeholders.
Diego Koenig
Vice President M&A
- MBA from Nanyang Business School in Singapore.
- M.A. in Strategy and International Management from the University of St. Gallen in Switzerland.
- 2022, joined Pharmathen as Vice President M&A.
- Held various global corporate M&A roles since 2009 in the life-science and chemical sectors, including the role of Head of M&A for Covestro.
Eleni Lampaki
Vice President Legal
- LL.B. from Aristotle University of Thessaloniki and LL.M. in Commercial Law from the National and Kapodistrian University of Athens.
- Joined Pharmathen in 2023 as Senior Principal Legal Counsel and was appointed Vice President & Head of Legal in August 2026.
- More than 25 years of experience as an attorney and in-house legal counsel, advising multinational companies on corporate and commercial law, governance, compliance and regulatory matters across the pharmaceutical, FMCG and insurance sectors.
Joanna Nidecka
Vice President, Industrial Operations – Sapes Site
- Over 25 years of international experience in building growth-oriented business strategies, leading international, interdisciplinary teams and managing transformation projects (industrial restructuration, optimization of manufacturing and packaging processes, improving site efficiency and customer satisfaction) across pharmaceutical & dietary supplements. Results-oriented & innovative.
- Executive MBA from Kozminski University.
- M.Sc.Eng. in Chemical Engineering from Rzeszow University of Technology.
- Postgraduate Studies IT Krakow University of Science and Technology.
Konstantinos Papaioannou
Vice President Information Technology
- M.Sc. in Finance from Athens Laboratory of Business Administration & B.Sc. in Computer Science from University of Wollongong NSW Australia.
- 2007, started working at Pharmathen in Corporate Information Technology Department.
- ISO/IEC 27001 Certified – Foundation from the Professional Evaluation and Certification Board (PECB).
- Member of ISACA.
- Held Information Technology and Cost Accounting Senior positions in large corporations including Fulgor SA, Club Hotel Casino Loutraki and Creta Farms.
- Supported the growth and transformation of Pharmathen in the last 15 years, managing various fields of the Information Technology Department.
Meritxell Saborit Placias
Vice President Commercial - Partnerships, Strategy & Commercial Excellence
- MBA from the University of Barcelona.
- More than 15 years of international experience across APIs and finished dosage forms (FDFs).
- Joined Pharmathen in 2022 as Head of Europe in the Business Development Department and currently serves as Vice President Commercial – Partnerships, Strategy & Commercial Excellence.
- Proven track record across major pharmaceutical organizations in driving revenue growth and cultivating high-impact, long-term stakeholder partnerships.
Vicky Samara
Vice President R&D Global Generics - QP
- MBA from Kingston University London & Diploma in Chemistry from National and Kapodistrian University of Athens.
- 2001, joined Pharmathen holding several senior roles in Research & Development.
- Scientific achievements: 72 patent certificates and applications, development of more than 100 pharmaceutical products.
- Qualified Person appointed by the National Organization for Medicines (EOF).
- Developed innovative drug delivery technologies/products (PF ophthalmics, sustained release, complex injectables etc.) and supported their approval globally.
Anastasios Spyropoulos
Vice President Industrial Operations
- Diploma in Chemical Engineering (M.Sc.Eng.) from National Technical University of Athens (NTUA)
- B.Sc. in Chemical Engineering from Leeds University
- 2007, started working at Pharmathen holding several Senior positions in Manufacturing and Industrial Operations
- Over 20 years of experience in the Pharmaceutical industry